Advertisement
New Zealand markets closed
  • NZX 50

    11,796.21
    -39.83 (-0.34%)
     
  • NZD/USD

    0.5890
    -0.0016 (-0.27%)
     
  • NZD/EUR

    0.5527
    -0.0017 (-0.31%)
     
  • ALL ORDS

    7,817.40
    -81.50 (-1.03%)
     
  • ASX 200

    7,567.30
    -74.80 (-0.98%)
     
  • OIL

    83.00
    +0.27 (+0.33%)
     
  • GOLD

    2,409.90
    +11.90 (+0.50%)
     
  • NASDAQ

    17,104.36
    -289.95 (-1.67%)
     
  • FTSE

    7,895.85
    +18.80 (+0.24%)
     
  • Dow Jones

    37,904.51
    +129.13 (+0.34%)
     
  • DAX

    17,737.36
    -100.04 (-0.56%)
     
  • Hang Seng

    16,224.14
    -161.73 (-0.99%)
     
  • NIKKEI 225

    37,068.35
    -1,011.35 (-2.66%)
     
  • NZD/JPY

    91.0220
    -0.2320 (-0.25%)
     

Why Shares of Moderna, Novavax, and Ocugen Are Falling Today

Why Shares of Moderna, Novavax, and Ocugen Are Falling Today

Shares of Moderna (NASDAQ: MRNA) are off by 3.4%; Novavax (NASDAQ: NVAX) is down 5.1%; and Ocugen's (NASDAQ: OCGN) stock is in the red by a jaw-dropping 13.3%, all as of 3:34 p.m. EDT Friday. The U.S. Food and Drug Administration (FDA) might delay the decision on Moderna's jab for adolescents due to safety issues, according to a report from the Wall Street Journal.